{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042525","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.470171+00:00","generated_at":"2026-05-30T10:06:10.853746+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Celularity expects H1 2024 biomaterial revenue >$24M, Rebound >$9M; reaffirms $50-56M FY guidance","bullets":["Preliminary net revenue from biomaterial products exceeds $24M for six months ended June 30, 2024, surpassing full-year 2023 sales.","Acquired Rebound allograft matrix from Sequence LifeScience; generated >$9M in net revenue to date, reimbursed via HCPCS Q4296.","Reaffirms FY 2024 combined net sales guidance of $50-56M for biomaterial and biobanking businesses.","Plans to file Q2 2024 10-Q in coming weeks; working to regain Nasdaq listing compliance.","Product pipeline: Celularity Tendon Wrap 510(k) submission expected early 2025, FUSE Bone Void Filler H2 2025, Placental Matrix 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042525","json":"https://secwatch.observer/filing/0001493152-24-042525.json","markdown":"https://secwatch.observer/filing/0001493152-24-042525.md","text":"https://secwatch.observer/filing/0001493152-24-042525.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224042525/0001493152-24-042525-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224042525/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:06:10.853746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}